Insulet Corporation (PODD) : Thursdays money flow points at investors jumping to buy the stock on the weakness of price. $4.94 million worth of transactions were on upticks, whereas, the downticks accounted for $3.2 million worth of transactions. The net money flow was a positive $1.74 million and the uptick to downtick ratio was 1.54. However, the block trades showed a clear dominance of the bulls with a very healthy ratio of 3.63 in their favor. The net money flow into the stock was $1.09 million. The value of block trades done on downticks was only $0.42 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $1.51 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. Insulet Corporation (PODD) was trading at $32.77, down $0.04 during day. The stock slid -0.12% over the previous days close. For the week, the stock recorded 2.06% over the previous weeks close.
The stock has recorded a 20-day Moving Average of 8.69% and the 50-Day Moving Average is 9.57%. Shares have rallied 0.88% from its 1 Year high price. On Nov 6, 2015, the shares registered one year high at $40.21 and the one year low was seen on Feb 12, 2016. The 50-Day Moving Average price is $30.36 and the 200 Day Moving Average price is recorded at $31.47.
Insulet Corporation (NASDAQ:PODD): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $33.02 and $32.34 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $33.13. The buying momentum continued till the end and the stock did not give up its gains. It closed at $32.85, notching a gain of 0.12% for the day. The total traded volume was 645,919 . The stock had closed at $32.81 on the previous day.
In an insider trading activity, Sommer Regina O, director of Insulet Corp, unloaded 8,019 shares at an average price of $30.42 on May 25, 2016. The total amount of the transaction was worth $243,938, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Insulet Corporation is a medical device company engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin infusion system for people with insulin-dependent diabetes. The Companys principal offices are located in Billerica, Massachusetts. Features of the OmniPod System include two-part design, no tubing, and automated cannula insertion. The OmniPod System consists of two devices that communicate wirelessly: the OmniPod, a small, lightweight, disposable insulin infusion device worn beneath clothing; and the PDM, a handheld device much like a personal digital assistant that wirelessly programs the OmniPod with insulin delivery instructions. The OmniPod will operate up to 72 hours (but no more than 80 hours) after it is first activated. The OmniPod System does not have external tubing and features an automated, hands-free cannula insertion system.